tm logo
VIVANI MEDICAL
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 14 Aug 2024

Last Applicant/ Owned by

1315 SOUTH LOOP ROAD

ALAMEDA

CA

94502

Serial Number

97381960 filed on 26th Apr 2022

Registration Number

N/A

Correspondent Address

Scott B. Dunbar

Scott B. Dunbar

SYLMAR, CA 91342

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VIVANI MEDICAL

Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nan Read More

Classification Information


Class [010]
Medical Instrument Products


Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules; Electrotherapy medical devices for electrical nerve stimulation and recording, namely, neurostimulation devices, stimulating and recording electrode implants, visual prostheses and visual cortical implants; Cortical electrodes integrally attached to implantable cortical stimulators and other systems, namely, electrodes, stimulators, headpieces, and wearable video processors for the treatment of blindness; Surgical apparatus and instruments for the treatment of blindness; Medical apparatus and instruments for use in surgery for the treatment of blindness; Medical devices for the treatment of blindness


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Implantable drug delivery devices having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; Implantable drug delivery devices having a drug reservoir and a nanoporous membrane sold preloaded with a therapeutic agent, namely, an injectable device for time release of the therapeutic agent for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Nanoporous membranes used in drug delivery devices for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; Nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97381960

Mark Type

No Service/Collective Mark

Attorney Docket Number

No S-14

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Aug 2024SOU EXTENSION 2 GRANTED
15th Aug 2024SOU EXTENSION 2 FILED
15th Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Aug 2024SOU TEAS EXTENSION RECEIVED
21st Feb 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09th Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Feb 2024SOU EXTENSION 1 GRANTED
07th Feb 2024SOU EXTENSION 1 FILED
07th Feb 2024SOU TEAS EXTENSION RECEIVED
15th Aug 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT